OKYO Pharma Says OK-101 Achieves Statistical Significance For Multiple Signs And Symptoms Of Dry Eye Disease Including Ocular Pain Relief In Its First-in-Human Phase 2 Trial Of OK-101
OKYO Pharma 表示，OK-101 在其首个 OK-101 人体 2 期试验中对包括眼痛缓解在内的干眼病的多种体征和症状具有统计学意义